Senseonics Holdings, Inc. (SENS)
Makes implantable sensors that continuously monitor blood sugar for diabetics.
$4.92-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-49.7%
The outlook
Analysts lean bullish on SENS with an average buy rating, and the median price target sits roughly 172% above the current price. However, the stock is trading well below both its 50- and 200-day moving averages and sits near its 52-week low, reflecting a weak recent trend. The overall picture shows a disconnect between analyst optimism and current price momentum.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +172% vs current price
Analyst price target
~12-month · 5 analysts$13.40average target+172.4% vs now
Now $4.92
Low $8.00High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$256.8M
52-wk high
$11.58
52-wk low
$4.79
50-day avg
$5.99
200-day avg
$6.59
Trailing P/E
—